Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti(Veneto Institute of Molecular Medicine), Pier Paolo Pandolfi(University of Turin), Andrea L. Richardson(Johns Hopkins University), William J. Haveman(Beth Israel Deaconess Medical Center), Katia Sampieri(Cancer Genetics (United States)), Ainara Egia(Beth Israel Deaconess Medical Center), Leonardo Salmena(Cancer Genetics (United States)), John G. Clohessy(Memorial Sloan Kettering Cancer Center), Jiangwen Zhang(Harvard University), Caterina Nardella(Beth Israel Deaconess Medical Center), Edi Brogi(Memorial Sloan Kettering Cancer Center), Lloyd C. Trotman(Cold Spring Harbor Laboratory), Arkaitz Carracedo(Ikerbasque)
Cited by 579
Related Papers
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Cellular Senescence: Aging, Cancer, and Injury
|Physiological Reviews|2019|1.3k